NeuTec Pharma plc ('NeuTec' or the 'Company')

The Board of NeuTec notes the recent movement in the Company's share price.  The 
Company is currently in discussions which may or may not lead to an offer being 
made for the whole of the issued and to be issued share capital of the 
Company.

There can be no certainty that agreement will be reached and an offer made.

A further announcement will be made as appropriate.

In accordance with Rule 2.10 of the City Code on Takeovers and Mergers, NeuTec
announces that it has in issue 29,058,636 ordinary shares of 25 pence each. The
International Securities Identification Number ('ISIN') for NeuTec ordinary
shares is GB0031275315.

Enquiries:

NeuTec Pharma plc
Professor James Burnie, CEO            Telephone: +44 (0)161 276 8827

Hoare Govett Limited                   Telephone: +44 (0)20 7678 8000
Justin Jones
Andrew Foster
Sean Wegerhoff

Hoare Govett Limited is acting for NeuTec and no-one else in connection with the
possible offer and will not be responsible to any other person for providing the
protections afforded to clients of Hoare Govett Limited or for providing advice
in relation to the possible offer.